FDA Adverse Event
Injury
Summary report: N
MIRRAGEN ADVANCED WOUND MATRIX
MDR report key: 18149786
·
Received November 15, 2023
Report
- Report Number
- MW5148179
- Event Type
- Injury
- Date Received
- November 15, 2023
- Date of Event
- September 14, 2023
- Report Date
- November 13, 2023
- Manufacturer
- ETS WOUND CARE LLC.
- Product Code
- QSZ
- Adverse Event
- Yes
- Report Source
- Voluntary report
- Reporter Location
- CA, US
- Reporter Occupation
- PATIENT
- Health Professional
- *
Narratives
Description of Event or Problem · 0
I AM BEING TREATED FOR SLOW HEALING WOUND , A COMBINATION ARTERIAL AND VENOUS ULCER. I HAD BEEN USING PICO 7 WOUND VAC WHICH HAD REDUCED THE SIZE OF THE WOUND AND I HAD NO PAIN. ON (B)(6) 2023 DURING MY 10:00 AM APPOINTMENT, A NEW TREATMENT WAS ADDED. IT WAS MIRRRAGEN ETS, A "RESORBABLE BORATE GLASS WOUND MANAGEMENT DEVICE". ABOUT 2:00 PM I STARTED TO HAVE PAIN IN THE WOUND AND IT INCREASED INTO THE EVENING AND OVERNIGHT. I CALLED THE DOCTOR'S OFFICE AND STOPPED USING. AT MY NEXT WEEKLY APPOINTMENT, THE WOUND WAS LARGER AND DEEPER AND DOCTOR REMARKED ABOUT THE LOOK OF THE WOUND. I HAVE NOT BEEN WITHOUT PAIN SINCE THAT TREATMENT.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 912663 | MIRRAGEN ADVANCED WOUND MATRIX | ABSORBABLE SYNTHETIC WOUND DRESSING | QSZ | ETS WOUND CARE LLC. | 0404180-1 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 89 YR | Female | Required Intervention| O | CEQUA FOR DRY EYES.| FOLIC ACID AND ONE BABY ASPIRIN.| METHOTREXATE.| MULTIVITAMINS. |